Nutex Health Inc. Reports Restated Financial Results for 2024
FULL YEAR 2024 HIGHLIGHTS:
- Total revenue of $479.9 million for the year 2024 versus $247.6 million for 2023, an increase of 93.8%
- Net income attributable to Nutex Health Inc. of $52.1 million for 2024 versus a net loss of $45.8 million for 2023
- Diluted income per share of $9.69 for 2024 compared to a loss per share of $10.39 for 2023
- EBITDA recorded at $98.8 million for 2024, up from a negative $(22.5) million for 2023
- Adjusted EBITDA of $124.1 million for 2024, an increase of 1046.1% compared to $10.8 million for 2023
- Net cash from operating activities totaled $23.2 million for the year 2024
Nutex Health Inc. (NASDAQ: NUTX) has announced its restated financial results for the fiscal year 2024, which ended on December 31, 2024. The impressive financial performance underscores the company’s ability to significantly enhance its revenue and operational efficiency as a leading healthcare provider in the United States.
Key Highlights of the Restated Financial Results
A detailed review of the financial performance reveals substantial growth for Nutex Health Inc. over the year 2024. The company achieved a notable 93.8% increase in total revenue, reaching $479.9 million, greatly surpassing 2023's revenues of $247.6 million. This remarkable growth has also translated into a net income of $52.1 million in 2024, a sharp contrast to the loss of $45.8 million the year prior.
Moreover, Nutex’s earnings per share saw a rebound, with diluted earnings reported at $9.69 for 2024, compared to a loss of $10.39 in 2023, illustrating the company's path to recovery and profitability.
Annual Restatement Justification
The Audit Committee of Nutex Health determined that the previously published consolidated financial statements for 2024 needed correcting. Changes primarily involved non-cash adjustments pertaining to reclassifications of stock-based compensation obligations, accounts payable, and tax expenses. These adjustments, which affected several balance sheet accounts, resulted in increased liabilities and a decrease in equity, with the overall net income affected minimally.
Despite these adjustments, the primary financial metrics showcased strong performance. For example, total liabilities increased by just 2.9%, while total equity decreased by 6.6%. The adjustments demonstrate that Nutex Health continues to operate with robust revenue generation and maintains its growth trajectory.
Quarterly Performance Analysis
In the fourth quarter of 2024, Nutex Health’s total revenue peaked at $257.6 million, a staggering increase compared to the $69.7 million reported for Q4 of 2023. Mature hospitals that opened prior to December 31, 2021 contributed significantly to this growth, experiencing a 175.6% revenue increase.
Operational Achievements and Future Outlook
The operational side also reflects enhancements, with a marked improvement in operating income. The company reported an operating income of $114.3 million in Q4 2024, demonstrating a notable turnaround compared to the operating loss of $26.1 million the prior year. Nutex Health’s hospital division witnessed a total of 45,444 visits during this quarter, marking a 9.8% increase from the same period in 2023.
Looking ahead, Nutex Health is poised to capitalize on its financial momentum and strategic initiatives established in 2024, focusing on expansion and enhancing healthcare delivery systems across the country. Understanding the significance of prudent cash management, the company ended the year with $40.6 million in cash and cash equivalents, reinforcing consumer and investor confidence.
About Nutex Health Inc.
Founded in 2011 and headquartered in Houston, Nutex Health Inc. operates as a significant healthcare management entity with two primary divisions: the Hospital Division manages micro-hospitals and specialty hospitals, while the Population Health Management Division expands access to care through provider networks. Nutex Health continues to leverage its innovative models to enhance patient outcomes and financial returns.
Frequently Asked Questions
1. What were the key financial highlights of Nutex Health in 2024?
Nutex Health reported a total revenue of $479.9 million, a net income of $52.1 million, and an Adjusted EBITDA of $124.1 million for 2024.
2. How did the company's performance compare with 2023?
2024 saw a significant improvement, with total revenue up by 93.8% and a switch from a net loss in 2023 to profitability in 2024.
3. What adjustments were made to the financial statements?
The financial statements were restated to correct non-cash adjustments related to stock-based compensation and certain classifications on the balance sheet.
4. How does Nutex Health plan to future-proof its growth?
The company plans to continue focusing on operational efficiency, strategic expansion, and entry into new markets, leveraging its innovative healthcare models.
5. What is Nutex Health’s approach to healthcare management?
Nutex Health emphasizes integrated healthcare delivery through micro-hospitals and physician networks to improve patient care and operational performance.
